Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - gemcitabine hydrochloride - powder for solution for infusion - 2 gram(s) - pyrimidine analogues; gemcitabine

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - gemcitabine - powder for solution for infusion - 1 gram(s) - pyrimidine analogues; gemcitabine

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - gemcitabine - powder for solution for infusion - 2 gram(s) - pyrimidine analogues; gemcitabine

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - gemcitabine - powder for solution for infusion - 200 milligram(s) - pyrimidine analogues; gemcitabine

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - gemcitabine hydrochloride - concentrate for solution for infusion - 38 milligram(s)/millilitre - pyrimidine analogues; gemcitabine

Israel - English - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - lyophilic powder for concentrated infusion - gemcitabine as hydrochloride 1 g/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Israel - English - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - lyophilic powder for concentrated infusion - gemcitabine as hydrochloride 1 g/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - fluorouracil - solution for injection/infusion - 50 milligram(s)/millilitre - pyrimidine analogues; fluorouracil

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - fluorouracil - cream - 5 percent weight/weight - pyrimidine analogues; fluorouracil

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - fluorouracil - solution for injection/infusion - 50 milligram(s)/millilitre - pyrimidine analogues; fluorouracil